Wei Yang et al., 2025-12: Screen identifying mebendazole as an anti-AML agent that arrests cells in G2/M through tubulin alpha-1A and triggers ZBP-1-mediated PANoptosis, with xenograft activity.
Mechanically, MBD inhibits the cell cycle in G2/M phase by inhibiting tubulin α1A (TUBA1A) and promotes ZBP-1 mediated PANoptosis in AML cells.
Wei Yang et al., 2025-12: Screen identifying mebendazole as an anti-AML agent that arrests cells in G2/M through tubulin alpha-1A and triggers ZBP-1-mediated PANoptosis, with xenograft activity. Study type: cell lines plus mouse xenografts (AML lines and patient-derived primary AML cells). N: not stated in the abstract. Country: China (Shenzhen University). Dose: not stated in the abstract text captured. Route/schedule: not stated in the abstract. Funder: not stated in the record. Declared conflicts: 'The authors declare that they have no competing interest.' Comparator: untreated controls and normal mice for toxicity.
